GeneOne Life Science, Inc. announces that it has received approval from the South Korean Ministry of Food and Drug Safety (KMFDS) for an Investigational New Drug application for a Phase I/IIa study of...

Seoul, South Korea based DNA vaccine developer GeneOne Life Science yesterday announced the initiation of a collaborative research program with Inovio Pharmaceuticals to test and advance a DNA-based...

By

GeneOne Life Science Inc., which partnered with Inovio Pharmaceuticals, Inc. to develop Inovio’s MERS vaccine (GLS-5300), announced Monday the filing of an Investigational New Drug Application (IND)...